Liu Y - Search Results

1

Glutaredoxin Desensitizes Lens to Oxidative Stress by Connecting and Integrating Specific Signaling and Transcriptional Regulation for Antioxidant Response.

Fan Q, Zhang Y, Liu Y, Yang J, Li D, Tang Y, Cai L, Zhao Z, Zhou P, Lu Y. Fan Q, et al. Among authors: liu y. Cell Physiol Biochem. 2016;39(5):1813-1826. doi: 10.1159/000447881. Epub 2016 Oct 17. Cell Physiol Biochem. 2016. PMID: 27744453 Free article.

2

Hippocalcin-like 1 suppresses hepatocellular carcinoma progression by promoting p21(Waf/Cip1) stabilization by activating the ERK1/2-MAPK pathway.

Zhang Y, Liu Y, Duan J, Yan H, Zhang J, Zhang H, Fan Q, Luo F, Yan G, Qiao K, Liu J. Zhang Y, et al. Among authors: liu j, liu y. Hepatology. 2016 Mar;63(3):880-97. doi: 10.1002/hep.28395. Epub 2016 Feb 3. Hepatology. 2016. PMID: 26659654

3

Cholesterol depletion sensitizes gallbladder cancer to cisplatin by impairing DNA damage response.

Zhang Y, Liu Y, Duan J, Wang H, Zhang Y, Qiao K, Wang J. Zhang Y, et al. Among authors: liu y. Cell Cycle. 2019 Dec;18(23):3337-3350. doi: 10.1080/15384101.2019.1676581. Epub 2019 Oct 10. Cell Cycle. 2019. PMID: 31599189 Free PMC article.

4

AMPK induces degradation of the transcriptional repressor PROX1 impairing branched amino acid metabolism and tumourigenesis.

Wang Y, Luo M, Wang F, Tong Y, Li L, Shu Y, Qiao K, Zhang L, Yan G, Liu J, Ji H, Xie Y, Zhang Y, Gao WQ, Liu Y. Wang Y, et al. Among authors: liu j, liu y. Nat Commun. 2022 Nov 24;13(1):7215. doi: 10.1038/s41467-022-34747-y. Nat Commun. 2022. PMID: 36433955 Free PMC article.

5

CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer.

Liu Y, Wang F, Yan G, Tong Y, Guo W, Li S, Qian Y, Li Q, Shu Y, Zhang L, Zhang Y, Xia Q. Liu Y, et al. Cancer Lett. 2024 Jul 28;595:217006. doi: 10.1016/j.canlet.2024.217006. Epub 2024 May 31. Cancer Lett. 2024. PMID: 38823763

6

Liu Y, Zhang Y, Wang S, Dong QZ, Shen Z, Wang W, Tao S, Gu C, Liu J, Xie Y, Qin LX. Liu Y, et al. Among authors: liu j. Hepatology. 2017 Dec;66(6):1894-1909. doi: 10.1002/hep.29337. Hepatology. 2017. PMID: 28646551

7

C24-Ceramide Drives Gallbladder Cancer Progression Through Directly Targeting Phosphatidylinositol 5-Phosphate 4-Kinase Type-2 Gamma to Facilitate Mammalian Target of Rapamycin Signaling Activation.

Zhang Y, Wang H, Chen T, Wang H, Liang X, Zhang Y, Duan J, Qian S, Qiao K, Zhang L, Liu Y, Wang J. Zhang Y, et al. Among authors: liu y. Hepatology. 2021 Feb;73(2):692-712. doi: 10.1002/hep.31304. Epub 2020 Nov 26. Hepatology. 2021. PMID: 32374916

8

GSTM3 deficiency impedes DNA mismatch repair to promote gastric tumorigenesis via CAND1/NRF2-KEAP1 signaling.

Chen T, Jinlin D, Wang F, Yuan Z, Xue J, Lu T, Huang W, Liu Y, Zhang Y. Chen T, et al. Among authors: liu y. Cancer Lett. 2022 Jul 10;538:215692. doi: 10.1016/j.canlet.2022.215692. Epub 2022 Apr 27. Cancer Lett. 2022. PMID: 35487311

9

Hippocalcin-Like 1 blunts liver lipid metabolism to suppress tumorigenesis via directly targeting RUVBL1-mTOR signaling.

Chen T, Yuan Z, Lei Z, Duan J, Xue J, Lu T, Yan G, Zhang L, Liu Y, Li Q, Zhang Y. Chen T, et al. Among authors: liu y. Theranostics. 2022 Oct 24;12(17):7450-7464. doi: 10.7150/thno.75936. eCollection 2022. Theranostics. 2022. PMID: 36438486 Free PMC article.

10

Histone methyltransferase KMT5C drives liver cancer progression and directs therapeutic response to PARP inhibitors.

Tong Y, Wang F, Li S, Guo W, Li Q, Qian Y, Li L, Zhao H, Zhang Y, Gao WQ, Liu Y. Tong Y, et al. Among authors: liu y. Hepatology. 2024 Jul 1;80(1):38-54. doi: 10.1097/HEP.0000000000000559. Epub 2023 Aug 9. Hepatology. 2024. PMID: 37556368

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209,791 results

Search Page

Filters